Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study

BACKGROUND: New prognostic markers may be of value in determining survival and informing decisions of adjuvant treatment in the heterogeneous group of soft tissue sarcomas known as malignant fibrous sarcomas (MFS). Increased CD44 expression has been associated with a better outcome in cancers such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Matuschek, Christiane, Lehnhardt, Marcus, Gerber, Peter Arne, Poremba, Christopher, Hamilton, Jackson, Lammering, Guido, Orth, Klaus, Budach, Wilfried, Bojar, Hans, Bölke, Edwin, Peiper, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942188/
https://www.ncbi.nlm.nih.gov/pubmed/24491153
http://dx.doi.org/10.1186/2047-783X-19-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942188/
https://www.ncbi.nlm.nih.gov/pubmed/24491153
http://dx.doi.org/10.1186/2047-783X-19-6

Ejemplares similares